Self EfficacyNCT05614674
The Examination of Relationship Between Self-Efficacy in People With Chronic Low Back Pain
An observational study of Self Efficacy, run by Suleyman Demirel University.
Trial summary
Self-efficacy is defined as a person's confidence or belief that one can achieve a certain behavioral or cognitive state. Self-efficacy is one of the most important assesment parameters in the self-management model. Read more about this study
- Who is it for?
- Ages 30 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Self Efficacy
- How many people
- 162 participants
- Where
- No sites listed yet
- Study dates
- Nov 2022to May 2023
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Study group will consist of 30-65 years old people who will be agreed to take part in the study. There will be two groups. 1 of them is healthy group and the other is for people with low back pain. The partipicians will be literate enough to answer the questions in scales and questionnares by themselves
Who may be able to join
- Being minimum 30 maximum 65 years old
- To be literate
- Accepting to take part in the study
- Inclusion Criterias For Partipicians with Low Back Pain Group:
- Being minimum 30 maximum 65 years old
- Minimum 3 score from Visual Analog Scale (VAS)
Show all 9Show fewer
- Having low back pain for at least 3 months of time
- To be literate
- Accepting to take part in the study
Who cannot join
- Any kind of surgery in low back area
- Surgery story in lower extremities
- Acute low back pain
- Having a neurological disorder
- Having a rheumatological disease which may cause to low back pain
- Having a herniated disc that presses on the sacral nerves
- Being pregnant
Trial locations and contacts
No sites are listed yet.
About this study
Official title: The Examination of Relationship Between Self-Efficacy and Sensorial, Perceptual and Motor Skills in People With Chronic Low Back Pain A Cross-Sectional Study
Self-efficacy is defined as a person's confidence or belief that one can achieve a certain behavioral or cognitive state. Self-efficacy is one of the most important assesment parameters in the self-management model. It is accepted that patients with chronic low back pain with high self-efficacy have a better prognosis than those with low self-efficacy. Due to the complex nature of pain; The relationship between psychological and physical parameters such as pain catastrophy, disability level, depression, physical performance, self-efficacy, pain intensity and fear avoidance arouses curiosity. The aim of this cross-sectional study is to examine the relationship between the level of self-efficacy and sensory, perceptual and motor skills in people with chronic low back pain.
- Conditions
- Self Efficacy
- Keywords
- Back Pain, Propioception, Depression, Pain Catastrophizing, Flexibility, Balance
- Medical subject headings
- Back Pain, Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Healthy group | People who don't suffer from low back pain | |
| People with low back pain | People who are suffering from low back pain. The pain level has to be at least 3 out of 10 according to Visual Analog Scale (VAS) to be in this group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Visual Analog Scale (VAS)
Measured: Baseline
Pain Self-Efficacy Questionnaire (PSEQ)
Measured: Baseline
Proprioception Measurement with G-Pro Phone App
Measured: Baseline
Beck Depression Inventory (BDI)
Measured: Baseline
Pain Catastrophizing Scale (PCS)
Measured: Baseline
Sit and Reach Test (SRT)
Measured: Baseline
Multidirectional Reach Test
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Nov 2022
- Study startNov 2022 (estimated)
- Primary completionJan 2023 (estimated)
- Study completionMay 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Self EfficacyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 162 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Suleyman Demirel University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Burak Kara, Suleyman Demirel University
- Investigators
- Burak Kara, Bachelor, Principal investigator, Suleyman Demirel University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05614674
- Sponsor's protocol ID
- 72867572-050.01.04-379338
- Status last verified
- Nov 2022
- First submitted
- 5 Nov 2022
- Last updated
- 14 Nov 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Examination of Relationship Between Self-Efficacy and Sensorial, Perceptual and Motor Skills in People With Chronic Low Back Pain A Cross-Sectional Study
- ClinicalTrials.gov ID
- NCT05614674
- Acronym / sponsor ID
- 72867572-050.01.04-379338
- Conditions
- Self Efficacy
- Keywords
- Back Pain, Propioception, Depression, Pain Catastrophizing, Flexibility, Balance
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 162 participants (estimated)
- Lead sponsor
- Suleyman Demirel UniversityUniversity, hospital or other
- Study start
- Nov 2022 (estimated)
- Primary completion
- Jan 2023 (estimated)
- Study completion
- May 2023 (estimated)
- First posted
- 14 Nov 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Self-efficacy is defined as a person's confidence or belief that one can achieve a certain behavioral or cognitive state. Self-efficacy is one of the most important assesment parameters in the self-management model. It is accepted that patients with chronic low back pain with high self-efficacy have a better prognosis than those with low self-efficacy. Due to the complex nature of pain; The relationship between psychological and physical parameters such as pain catastrophy, disability level, depression, physical performance, self-efficacy, pain intensity and fear avoidance arouses curiosity. The aim of this cross-sectional study is to examine the relationship between the level of self-efficacy and sensory, perceptual and motor skills in people with chronic low back pain.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Healthy group | – | –People who don't suffer from low back pain |
| People with low back pain | – | –People who are suffering from low back pain. The pain level has to be at least 3 out of 10 according to Visual Analog Scale (VAS) to be in this group. |
Who may qualify
- Ages
- 30 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Study group will consist of 30-65 years old people who will be agreed to take part in the study. There will be two groups. 1 of them is healthy group and the other is for people with low back pain. The partipicians will be literate enough to answer the questions in scales and questionnares by themselves
Key inclusion criteria (9 listed)
- Being minimum 30 maximum 65 years old
- To be literate
- Accepting to take part in the study
- Being minimum 30 maximum 65 years old
- Minimum 3 score from Visual Analog Scale (VAS)
Key exclusion criteria (7 listed)
- Any kind of surgery in low back area
- Surgery story in lower extremities
- Acute low back pain
- Having a neurological disorder
- Having a rheumatological disease which may cause to low back pain
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Visual Analog Scale (VAS)
Time frame: Baseline
Pain Self-Efficacy Questionnaire (PSEQ)
Time frame: Baseline
Proprioception Measurement with G-Pro Phone App
Time frame: Baseline
Beck Depression Inventory (BDI)
Time frame: Baseline
Pain Catastrophizing Scale (PCS)
Time frame: Baseline
Sit and Reach Test (SRT)
Time frame: Baseline
Multidirectional Reach Test
Time frame: Baseline
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Nov 2022.
Related trials for Self Efficacy
Recruiting
Efficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis
Rhumatoid Arthisis, Spondyloarthritis (SA)
Not yet recruiting
Effect of a Novel Episiotomy Repair Simulator on Midwifery Students' Self-Efficacy and Anxiety
Episiotomy Repair Training
Not yet recruiting
AI Smart Glasses Feedback for Intubation Training in Medical Students
Intubation, Intratracheal, Medical Education
Recruiting
Bonding Before Birth: A mHealth Intervention for First-time Expectant Couples
Anxiety, Pregnancy
Not yet recruiting
Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health
Hypertension (HTN), CKD - Chronic Kidney Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Burak Kara, Bachelor principal investigator
Suleyman Demirel University
Questions about this trial
What is this clinical trial studying?
An observational study of Self Efficacy, run by Suleyman Demirel University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Burak Kara, Bachelor (+905453765972, ptburakkara@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Visual Analog Scale (VAS) (time frame: Baseline). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2022.